Ripisartan

TargetMol
Product Code: TAR-T28540
Supplier: TargetMol
CodeSizePrice
TAR-T28540-1mg1mg£224.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28540-5mg5mg£448.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28540-10mg10mg£624.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28540-25mg25mg£938.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28540-50mg50mg£1,243.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28540-100mg100mg£1,645.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28540-500mg500mg£3,227.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Ripisartan is a potent and specific angiotensin II receptor antagonist. Ripisartan antagonizes the angiotensin II sympathetic-mediated tachycardiac response.
CAS:
148504-51-2
Formula:
C23H22N8O
Molecular Weight:
426.484
Pathway:
Endocrinology/Hormones
Purity:
0.98
SMILES:
CCCc1nc(C)n2[nH]c(=O)nc2c1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1
Target:
RAAS

References

1. Xu Y, Menon V, Jugdutt BI. Cardioprotection after angiotensin II type 1 blockade involves angiotensin II type 2 receptor expression and activation of protein kinase C-epsilon in acutely reperfused myocardial infarction in the dog. Effect of UP269-6 and losartan on AT1 and AT2-receptor expression and IP3 receptor and PKCepsilon proteins. J Renin Angiotensin Aldosterone Syst. 2000 Jun;1(2):184-95. PubMed PMID: 11967812. 2. Moudgil R, Xu Y, Menon V, Jugdutt BI. Effect of chronic AT(1) receptor antagonism on postischemic functional recovery and AT(1)/AT(2) receptor proteins in isolated working rat hearts. J Cardiovasc Pharmacol Ther. 2001 Apr;6(2):183-8. PubMed PMID: 11509925. 3. Moudgil R, Menon V, Xu Y, Musat-Marcu S, Kumar D, Jugdutt BI. Postischemic apoptosis and functional recovery after angiotensin II type 1 receptor blockade in isolated working rat hearts. J Hypertens. 2001 Jun;19(6):1121-9. PubMed PMID: 11403362. 4. O'Brien DW, Xu Y, Menon V, Jugdutt BI. Efficacy of pretreatment with the angiotensin II type 1 receptor blocker UP269-6 and losartan in the dog: effect on hemodynamics and ischemia-reperfusion. J Cardiovasc Pharmacol Ther. 2000 Apr;5(2):129-37. PubMed PMID: 11150392.